- Accession Number:
- Form Type:
- Zero Holdings:
- Publication Time:
- 2017-07-21 16:01:05
- Reporting Period:
- Filing Date:
- Accepted Time:
- 2017-07-21 16:01:05
- SEC Url:
- Form 4 Filing
|Cik||Name||Symbol||Sector (SIC)||IRS No|
|879169||Incyte Corp||INCY||Services-Commercial Physical & Biological Research (8731)||943136539|
|Cik||Name||Reported Address||Insider Title||Director||Officer||Large Shareholder||Other|
|1673776||H Steven Stein||1801 Augustine Cut-Off |
Wilmington DE 19803
|Evp & Chief Medical Officer||No||Yes||No||No|
|Sec. Name||Acquisiton - Disposition||Date||Amount||Price||Remaning Holdings||Equity Swap Involved||Form Type||Code||Nature of Ownership||Explanation|
|Equity Swap Involved||Form Type||Code||Nature of Ownership||Explanation|
|Sec. Name||Sec. Type||Acquisiton - Disposition||Date||Amount||Price||Amount - 2||Price - 2|
|Common Stock||Non-Qualified Stock Option (right to buy)||Disposition||2017-07-20||1,191||$0.00||1,191||$88.68|
|Common Stock||Non-Qualified Stock Option (right to buy)||Disposition||2017-07-20||4,772||$0.00||4,772||$83.83|
|Common Stock||Non-Qualified Stock Option (right to buy)||Disposition||2017-07-20||522||$0.00||522||$95.76|
|Remaning Holdings||Exercise Date||Expiration Date||Equity Swap Involved||Transaction Form Type||Transaction Code||Nature of Ownership|
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
- Represents weighted average sale price. Actual sale prices ranged from $129.57 - $132.10.
- Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated.
- This includes an 18,165 aggregate of shares of common stock issuable pursuant to previously reported restricted stock units that have not vested
- Beginning March 2, 2015, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
- Beginning July 15, 2016, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.
- Beginning January 7, 2016, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years